Literature DB >> 10556008

Squamous cell carcinoma of the thyroid: outcome of treatment in 16 patients.

A M Cook1, L Vini, C Harmer.   

Abstract

AIMS AND METHODS: Squamous cell carcinoma of the thyroid is very rare and has a poor prognosis. Treatment and outcome were retrospectively analysed in a consecutive series of 16 patients treated at the Royal Marsden Hospital, with the aim of establishing guidelines for management.
RESULTS: Twelve of the 16 patients had locoregional disease only at presentation and four had distant metastases. Eight of the 16 underwent surgery and four were given post-operative radiotherapy. Radiotherapy alone was used in six patients unsuitable for surgery. Median survival was 16 months. There were three long-term survivors; each had localized disease treated with surgery and post-operative radiotherapy. Patients treated with surgery alone all developed local recurrence. Two of six patients treated with radiotherapy alone had a partial response but all subsequently developed progressive local disease. Chemotherapy was used in two patients with no response.
CONCLUSIONS: Long-term survival is possible if disease is diagnosed early and is completely resected. Surgery should be followed by radical dose radiotherapy. Copyright 1999 Harcourt Publishers Ltd.

Entities:  

Mesh:

Year:  1999        PMID: 10556008     DOI: 10.1053/ejso.1999.0715

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  17 in total

1.  Primary Squamous Cell Carcinoma in the Thyroid Gland: A Population-Based Analysis Using the SEER Database.

Authors:  Shuwen Yang; Cunfu Li; Xiao Shi; Ben Ma; Weibo Xu; Hongyi Jiang; Wanlin Liu; Qinghai Ji; Yu Wang
Journal:  World J Surg       Date:  2019-05       Impact factor: 3.352

2.  A patient with primary squamous cell carcinoma of the thyroid intermingled with follicular thyroid carcinoma that remains alive more than 8 years after diagnosis.

Authors:  Tae Sik Jung; Young Lyun Oh; Young-Ki Min; Myung-Shik Lee; Moon-Kyu Lee; Kwang-Won Kim; Jae Hoon Chung
Journal:  Korean J Intern Med       Date:  2006-03       Impact factor: 2.884

3.  Primary squamous cell carcinoma (PSCC) of the thyroid: a case report and review of the literature.

Authors:  Bai-Hui Sun; Shi-Tong Yu; Jun-Na Ge; Shang-Tong Lei
Journal:  Gland Surg       Date:  2020-04

4.  Primary Squamous Cell Carcinoma of Thyroid - A Rare Malignant Goitre.

Authors:  Vijendra S Shenoy; Raghavendra A Rao; Panduranga M Kamath; Vishnu Prasad; S Haseena
Journal:  Indian J Surg Oncol       Date:  2016-06-04

5.  Biological behavior of papillary carcinoma of the thyroid including squamous cell carcinoma components and prognosis of patients who underwent locally curative surgery.

Authors:  Yasuhiro Ito; Mitsuyoshi Hirokawa; Takuya Higashiyama; Minoru Kihara; Chisato Tomoda; Yuuki Takamura; Kaoru Kobayashi; Akihiro Miya; Akira Miyauchi
Journal:  J Thyroid Res       Date:  2011-09-18

6.  Collision tumor of the thyroid: follicular variant of papillary carcinoma and squamous carcinoma.

Authors:  Rohan R Walvekar; Subhadra V Kane; Anil K D'Cruz
Journal:  World J Surg Oncol       Date:  2006-09-19       Impact factor: 2.754

7.  Treatment optimization and prognostic considerations for primary squamous cell carcinoma of the thyroid.

Authors:  Wenlong Wang; Qianhui Ouyang; Chaoyang Meng; Lanyu Jing; Xinying Li
Journal:  Gland Surg       Date:  2019-12

8.  Is an aggressive approach justified in the management of an aggressive cancer--the squamous cell carcinoma of thyroid?

Authors:  Pranjal Kulshreshtha; Jaiprakash Singh; Nidhi Sugandhi; Anju Bansal; Dinesh Bhatnagar; Sunita Saxena
Journal:  Int Semin Surg Oncol       Date:  2007-03-27

9.  Liposarcoma of the thyroid.

Authors:  A Mitra; C Fisher; P Rhys-Evans; C Harmer
Journal:  Sarcoma       Date:  2004

10.  Palliative radiation in primary squamous cell carcinoma of thyroid: a rare case report.

Authors:  Sushmita Ghoshal; Tapesh Bhattacharyya; Ashwani Sood; Ruchita Tyagi
Journal:  Indian J Palliat Care       Date:  2013-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.